Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma

Journal of Urology

Volumn 184, Issue 5, 2010, Pages 1888-1894

  Winter, Hauke ^a   Meimarakis, Georgios ^a   Angele, Martin K ^a   Hummel, Manuela ^b   Staehler, Michael ^a   Hoffmann, Ralf Thorsten ^a   Hatz, Rudolf A ^a   Lhe, Florian ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Biometry and Epidemiology   (Germany)

Author keywords

Carcinoma, renal cell; Kidney; Lung; Lymph node dissection; Neoplasm metastasis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; LUNG HILUS; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDIASTINUM LYMPH NODE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY METASTASECTOMY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; CARCINOMA, RENAL CELL; KIDNEY TUMOR; LUNG NEOPLASMS; MEDIASTINUM; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RADIOGRAPHY; SECONDARY; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MEDIASTINUM; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77957849778     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.06.096     Document Type: Article

References (30)

1. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74
2. M. McCredie Bladder and kidney cancers Cancer Surv 19-20 1994 343
3. S. Hellsten, T. Berge, and F. Linell Clinically unrecognised renal carcinoma: aspects of tumor morphology, lymphatic and haematogenous metastatic spread Br J Urol 55 1983 166
4. J. Pfannschmidt, J. Klode, and T. Muley Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients Ann Thorac Surg 81 2006 448
5. J. Pfannschmidt, H. Hoffmann, and T. Muley Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Ann Thorac Surg 74 2002 1653
6. F. Loehe, S. Kobinger, and R.A. Hatz Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy Ann Thorac Surg 72 2001 225
7. S. Piltz, G. Meimarakis, and M.W. Wichmann Long-term results after pulmonary resection of renal cell carcinoma metastases Ann Thorac Surg 73 2002 1082
8. D. Lardinois, H. Suter, and H. Hakki Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer Ann Thorac Surg 80 2005 268
9. J.R. Izbicki, B. Passlick, and O. Karg Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer Ann Thorac Surg 59 1995 209
10. S. Margaritora, V. Porziella, and A. D'Andrilli Can accurate radiological evaluation avoid thoracotomic approach? Eur J Cardiothorac Surg 21 2002 1111
11. S. Diederich, M. Semik, and M.G. Lentschig Helical CT of pulmonary nodules in patients with extrathoracic malignancy: CT-surgical correlation AJR Am J Roentgenol 172 1999 353
12. M.J. Kroger, T. Menzel, and J.E. Gschwend Life quality of patients with metastatic renal cell carcinoma and chemo-immunotherapya pilot study Anticancer Res 19 1999 1553
13. A. Ravaud, B. Audhuy, and F. Gomez Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial Groupe Francais d'Immunotherapie J Clin Oncol 16 1998 2728
14. S.D. Fossa, A. Kramar, and J.P. Droz Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha Eur J Cancer 30A 1994 1310
15. R.J. Cerfolio, M.S. Allen, and C. Deschamps Pulmonary resection of metastatic renal cell carcinoma Ann Thorac Surg 57 1994 339
16. H.W. Pogrebniak, G. Haas, and W.M. Linehan Renal cell carcinoma: resection of solitary and multiple metastases Ann Thorac Surg 54 1992 33
17. J.P. Kavolius, D.P. Mastorakos, and C. Pavlovich Resection of metastatic renal cell carcinoma J Clin Oncol 16 1998 2261
18. G. Friedel, M. Hurtgen, and M. Penzenstadler Resection of pulmonary metastases from renal cell carcinoma Anticancer Res 19 1999 1593
19. S.C. Murthy, K. Kim, and T.W. Rice Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg 79 2005 996
20. H.S. Hofmann, H. Neef, and K. Krohe Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma Eur Urol 48 2005 77
21. S. Ercan, F.C. Nichols 3rd, and V.F. Trastek Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma Ann Thorac Surg 77 2004 1786
22. H.L. Abrams, R. Spiro, and N. Goldstein Metastases in carcinoma; analysis of 1000 autopsied cases Cancer 3 1950 74
23. J.A. Johnsen, and S. Hellsten Lymphatogenous spread of renal cell carcinoma: an autopsy study J Urol 157 1997 450
24. M. Riquet, G. Hidden, and B. Debesse Direct lymphatic drainage of lung segments to the mediastinal nodes An anatomic study on 260 adults J Thorac Cardiovasc Surg 97 1989 623
25. M.B. Faries, R.J. Bleicher, and X. Ye Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms Arch Surg 139 2004 870
26. D.E. Kang, R.L. White Jr, and J.H. Zuger Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma J Urol 171 2004 1806
27. J. Wu, Y. Ohta, H. Minato, and Y. Tsunezuka Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter Ann Thorac Surg 71 2001 1772
28. E.M. Toloza, L. Harpole, and D.C. McCrory Noninvasive staging of non-small cell lung cancer: a review of the current evidence Chest 123 suppl. 2003 137
29. B. Escudier, T. Eisen, and W.M. Stadler Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 2007 125
30. R.J. Motzer, T.E. Hutson, and P. Tomczak Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 2007 115